Crinetics Pharmaceuticals, Inc.
CRNX$34.63▲ 4.65% 24h
Crinetics Pharmaceuticals, Inc.CRNX$34.63
+$7.65(+28.34%)Past Year
Jun 25Sep 25Dec 25Mar 26Jun 26
Key statistics
Market cap
$3.63B
P/E ratio
—
EPS (diluted)
$-4.95
Dividend yield
0.00%
Dividend / share
$0.00
Revenue
$7.70M
Net income
$-465.32M
Net margin
-6046.2%
Gross margin
—
Dividends & financials
Crinetics Pharmaceuticals, Inc. (CRNX) reported revenue of $7.70M and net income of $-465.32M, or $-4.95 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.